Integrative Radiogenomic Profiling of Squamous Cell Lung Cancer

ArticleinCancer Research 73(20) · August 2013with17 Reads
DOI: 10.1158/0008-5472.CAN-13-1616 · Source: PubMed
Abstract
Radiation therapy is one of the mainstays of anti-cancer treatment, but the relationship between the radiosensitivity of cancer cells and their genomic characteristics is still not well-defined. Here we report the development of a high-throughput platform for measuring radiation survival in vitro and its validation by comparison to conventional clonogenic radiation survival analysis. We combined results from this high-throughput assay with genomic parameters in cell lines from squamous cell lung carcinoma, which is standardly treated by radiation therapy, to identify parameters that predict radiation sensitivity. We showed that activation of NFE2L2, a frequent event in lung squamous cancers, confers radiation resistance. An expression-based, in silico screen nominated inhibitors of PI3K as NFE2L2 antagonists. We showed that the selective PI3K inhibitor, NVP-BKM120, both decreased NRF2 protein levels and sensitized NFE2L2 or KEAP1 mutant cells to radiation. We then combined results from this high-throughput assay with single-sample gene set enrichment analysis (ssGSEA) of gene expression data. The resulting analysis identified pathways implicated in cell survival, genotoxic stress, detoxification, and innate and adaptive immunity as key correlates of radiation sensitivity. The integrative, high-throughput methods shown here for large-scale profiling of radiation survival and genomic features of solid-tumor derived cell lines should facilitate tumor radiogenomics and the discovery of genotype-selective radiation sensitizers and protective agents.
Project
Systematic efforts to sequence the cancer genome have identified large numbers of mutations and copy number alterations in human cancers. However, elucidating the functional consequences of these v…" [more]
Article
October 2013 · International Journal of Radiation OncologyBiologyPhysics · Impact Factor: 4.26
    Radiotherapy is one of the mainstays of anticancer treatment, but the relationship between the radiosensitivity of cancer cells and their genomic characteristics is still not well defined. Here, we report the development of a high-throughput platform for measuring radiation survival in vitro and its validation in comparison with conventional clonogenic radiation survival analysis. We combined... [Show full abstract]
    Article
    November 2006 · Nature Reviews Genetics · Impact Factor: 36.98
      Article
      November 2006 · Nature Reviews Molecular Cell Biology · Impact Factor: 37.81
        A new database of gene-expression responses to small molecules is available for determining the mechanisms of action of new molecules, studying the molecular basis of physiological processes and searching for potential therapies.The authors of this pilot connectivity map obtained mRNA expression profiles for human cell lines that were challenged with 164 different small molecules, representing... [Show full abstract]
        Discover more